Codex DNA Inc. (DNAY)
NASDAQ: DNAY
· Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM
Codex DNA Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 17.33M | 22.08M | 30M | 31.11M | 28.11M | 27.43M | 21.04M | 17.16M | 14.35M | 11.04M | 9.9M | 8.75M | 7.52M |
Cost of Revenue | 8.43M | 10.68M | 11.35M | 11.8M | 11.79M | 11.84M | 11.01M | 9.62M | 8.58M | 6.74M | 5.57M | 4.68M | 3.4M |
Gross Profit | 8.9M | 11.4M | 18.65M | 19.31M | 16.33M | 15.6M | 10.03M | 7.53M | 5.78M | 4.3M | 4.34M | 4.07M | 4.11M |
Operating Income | -35.05M | -40.95M | -39.8M | -40.93M | -47.49M | -48.97M | -53.49M | -51.68M | -44.72M | -38.13M | -28.45M | -23.31M | -19.03M |
Interest Income | 238K | 160K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -36.64M | -41.58M | -38.14M | -39.83M | -46.38M | -48.45M | -52.81M | -50.32M | -44.69M | -38.94M | -32.04M | -26.68M | -21.56M |
Net Income | -40.08M | -43.93M | -38.84M | -39.95M | -46.34M | -48.42M | -52.83M | -50.34M | -44.71M | -38.96M | -32.05M | -26.69M | -21.57M |
Selling & General & Admin | 29.25M | 34.64M | 37.62M | 37.72M | 38.72M | 38.62M | 36.08M | 33.99M | 29.7M | 25.13M | 20.9M | 16.75M | 13.3M |
Research & Development | 13.35M | 16.3M | 17.97M | 19.66M | 22.2M | 23.46M | 24.65M | 22.43M | 18.05M | 14.55M | 11.88M | 10.63M | 9.84M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42.6M | 50.93M | 55.59M | 57.38M | 60.92M | 62.08M | 60.73M | 56.42M | 47.75M | 39.67M | 32.78M | 27.38M | 23.14M |
Interest Expense | -1.45M | -1.48M | -3.44M | -2.43M | -1.8M | -1.22M | -1.42M | -1.35M | -1.27M | -1.37M | 1.19M | 977K | 739K |
Selling & Marketing Expenses | 8.68M | 11.61M | 14.59M | 15.68M | 16.84M | 16.49M | 14.84M | 13.97M | 12.08M | 10.9M | 10.03M | 8.94M | 7.91M |
Cost & Expenses | 51.04M | 61.61M | 66.94M | 69.18M | 72.71M | 73.92M | 71.74M | 66.04M | 56.33M | 46.42M | 38.35M | 32.06M | 26.55M |
Income Tax Expense | -20K | -22K | -63K | -43K | -33K | -24K | 22K | 20K | 16K | 14K | 13K | 11K | 9K |
Shares Outstanding (Basic) | 17.73M | 17.3M | 29.95M | 29.77M | 29.66M | 29.46M | 29.52M | 29.44M | 29.33M | 29.3M | 29.3M | 25.4M | 21.51M |
Shares Outstanding (Diluted) | 17.73M | 17.3M | 29.95M | 29.77M | 29.66M | 29.46M | 29.52M | 29.44M | 29.33M | 29.3M | 29.3M | 25.4M | 21.51M |
EPS (Basic) | -1.82 | -1.78 | -1.29 | -1.34 | -1.56 | -1.64 | -1.8 | -1.72 | -1.58 | -1.48 | -1.31 | -1.18 | -1.01 |
EPS (Diluted) | -1.82 | -1.78 | -1.29 | -1.34 | -1.56 | -1.64 | -1.8 | -1.72 | -1.58 | -1.48 | -1.31 | -1.18 | -1.01 |
EBITDA | -35.05M | -40.55M | -40.64M | -42.51M | -48.42M | -49.71M | -53.17M | -50.26M | -44.83M | -39.41M | -29.39M | -24.25M | -19.38M |
EBIT | -19.92M | -30.88M | -38.72M | -39.41M | -45.32M | -47.2M | -54.22M | -51.67M | -45.97M | -40.31M | -30.85M | -25.7M | -20.82M |
Depreciation & Amortization | 82.5K | 482.5K | -757.5K | -1.46M | -931K | -738K | 311K | 1.42M | 1.14M | 908K | 1.46M | 1.45M | 1.45M |